INNOVATIVE PHAR(00399) is proposed to be renamed as "Starlink Group Limited" and to increase its authorized share capital.
avigation Medicine Biotechnology (00399) announced that the board of directors recommends changing the company's English name from "Innov...
INNOVATIVE PHAR(00399) announced that the board of directors suggests changing the company's English name from "Innovative Pharmaceutical Biotech Limited" to "Starcoin Group Limited" and adopting the Chinese name "" as the company's second name, to replace the current name ""; and increasing the company's authorized share capital from 500 million HKD (divided into 500 billion shares) to 1.2 billion HKD (divided into 1.2 trillion shares).
Related Articles

CENTURY GINWA (00162): Ma Wenzhong appointed as Chairman of the Board

CSTONE PHARMA-B(02616) first disclosed two new dual-antibody molecular targets for autoimmune/inflammatory diseases.

China Securities Co., Ltd.: The market in July is expected to trade around the mid-year reports, focusing on overseas computing power chains and other directions.
CENTURY GINWA (00162): Ma Wenzhong appointed as Chairman of the Board

CSTONE PHARMA-B(02616) first disclosed two new dual-antibody molecular targets for autoimmune/inflammatory diseases.

China Securities Co., Ltd.: The market in July is expected to trade around the mid-year reports, focusing on overseas computing power chains and other directions.

RECOMMEND

U.S. Senate Passes “Big and Beautiful” Bill, Triggering Surge in Gold Amid Soaring Deficit Concerns
02/07/2025

Declining Demand Triggers Price Drop; Photovoltaic Glass Industry May Be Preparing for a New Round of Coordinated Production Cuts
02/07/2025

Surge in Prices of Chinese-Made Goods Highlights Tariff Impact on U.S. Consumers
02/07/2025